Clinical trial
An Open Label Phase II Study of Indisulam in Combination With Irinotecan in…
NCT00165867 · Eisai Limited, Industry · Completed
Key facts
| NCT number | NCT00165867 |
|---|---|
| Title | An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin |
| Lead sponsor | Eisai Limited, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | E7070 |
| Enrollment | 40 |
| Start date | Apr 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Oct 9, 2006 |
| Countries | France, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: